Clinical trial
Phase II Study Efficacy and Safety of Two Dosing Regimens of MN-001 in Patients…
NCT00295854 · MediciNova, Industry · Completed
Key facts
| NCT number | NCT00295854 |
|---|---|
| Title | Phase II Study Efficacy and Safety of Two Dosing Regimens of MN-001 in Patients With Interstitial Cystitis |
| Official title | A Phase II, Randomized, Double-blind, Placebo-controlled, Multi-center Study to Evaluate the Efficacy and Safety of Two Dosing Regimens of MN-001 in Patients With Interstitial Cystitis |
| Lead sponsor | MediciNova, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Interstitial Cystitis |
| Intervention type | Drug |
| Interventions | MN-001 BID, MN-001, Placebo |
| Enrollment | 296 |
| Start date | May 1, 2005 |
| Primary completion | Oct 1, 2006 |
| Completion | Oct 1, 2006 |
| First posted | Feb 24, 2006 |
| Last update posted | Jan 19, 2012 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: